Northern Trust’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$86.7K Sell
109,466
-1,584
-1% -$1.08K ﹤0.01% 4157
2026
Q1
$73.9K Buy
+111,050
New +$75.7K ﹤0.01% 4170
2025
Q4
Sell
-26,389
Closed -$20.5K 4470
2025
Q3
$20.5K Buy
26,389
+12,346
+88% +$16.7K ﹤0.01% 4372
2025
Q2
$19.9K Hold
14,043
﹤0.01% 4334
2025
Q1
$18.3K Hold
14,043
﹤0.01% 4345
2024
Q4
$20.1K Hold
14,043
﹤0.01% 4375
2024
Q3
$45.6K Hold
14,043
﹤0.01% 4232
2024
Q2
$33.1K Hold
14,043
﹤0.01% 4271
2024
Q1
$55K Buy
+14,043
New +$41.1K ﹤0.01% 4211

Other funds holding COCH

Northern Trust's COCH Position: Q2 2026 in Review

Northern Trust reduced its Envoy Medical (COCH) stake by 1.4% in Q2 2026, selling an estimated $1.08K and leaving 109,466 shares worth $86.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4157.

Northern Trust first reported a position in COCH in Q1 2024 and has held it in 9 quarters since. 32 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • Northern Trust held 109,466 shares of Envoy Medical worth $86.7K as of Q2 2026.
  • Northern Trust sold 1,584 Envoy Medical shares in Q2 2026, an estimated $1.08K.
  • Envoy Medical made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4157 holding.
  • Northern Trust first reported a position in Envoy Medical in Q1 2024 and has held it in 9 quarters since.
  • 32 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.